Clinical trial · Observational
Empyema Following Pneumonectomy for Non Small Cell Lung Cancer (NSCLC)
Incidence, Risk Factors and Outcome of Empyema Following Pneumonectomy for Non Small Cell Lung Cancer (NSCLC)
NCT01837186CI-TRIAL-00010110completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Empyema following pneumonectomy for Non Small Cell Lung Cancer (NSCLC) is a known problem that occurs in about 2% of pneumonectomy patients.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Non Small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- EFP
- description
- Empyema following pneumonectomy
- label
- nEFP
- description
- No empyema following pneumonectomy
Primary outcomes (1)
- measure
- Overall survival
- timeFrame
- 5 years from surgery
- description
- overall 5-year survival after empyema following pneumonectomy
Secondary outcomes (1)
- measure
- incidence rate
- timeFrame
- 1 and 5 years from surgery
- description
- incidence of empyema, accompanied with broncho-pleural fistula or not, divided in short term (less than 1 yr postoperatively) and long term (up to 5 years postoperatively) incidence.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Pneumonectomy for NSCLC Exclusion Criteria: * Pneumonectomy for other reasons (infectious pathology, trauma, mesothelioma, ...)
References
Publications (0)
Data not yet available
No reference posted for this study.